Cargando…
Renal Dysfunction and In‐Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy
BACKGROUND: The impact of estimated glomerular filtration rate (eGFR) on clinical short‐term outcomes after stroke thrombolysis with tissue plasminogen activator remains controversial. METHODS AND RESULTS: We analyzed 18 320 ischemic stroke patients who received intravenous tissue plasminogen activa...
Autores principales: | Rao, Zhen‐Zhen, Gu, Hong‐Qiu, Wang, Xian‐Wei, Xie, Xue‐Wei, Yang, Xin, Wang, Chun‐Juan, Zhao, Xingquan, Xian, Ying, Wang, Yi‐Long, Li, Zi‐Xiao, Xiao, Rui‐Ping, Wang, Yong‐Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818031/ https://www.ncbi.nlm.nih.gov/pubmed/31595836 http://dx.doi.org/10.1161/JAHA.119.012052 |
Ejemplares similares
-
Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023) -
Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke
por: Cheng, Xu-Dong, et al.
Publicado: (2023) -
Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013) -
Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023) -
In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
por: Yang, Yilin, et al.
Publicado: (2023)